Next Article in Journal
4-(4-(2-Bromoethyl)phenoxy)-2,3,5,6-tetrafluoropyridine
Next Article in Special Issue
2-(1-Methoxycarbonyl-2-phenyleth-1-yl)-1-benzylpyridin-1-ium Bromide
Previous Article in Journal
tert-Butyl N-Hydroxycarbamate (N-Boc-Hydroxylamine)
Previous Article in Special Issue
4-(4-Ethoxyphenyl)-5-(4-methoxyphenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2,8-Dibromo-6H,12H-6,12-epoxydibenzo[b,f][1,5]dioxocine

EaStCHEM School of Chemistry, University of St Andrews, North Haugh, St Andrews KY16 9ST, Fife, UK
*
Author to whom correspondence should be addressed.
Molbank 2023, 2023(3), M1729; https://doi.org/10.3390/M1729
Submission received: 24 August 2023 / Revised: 16 September 2023 / Accepted: 17 September 2023 / Published: 19 September 2023
(This article belongs to the Collection Molecules from Side Reactions)

Abstract

:
The title dibromodisalicylaldehyde, obtained as a by-product in the m-chloroperoxybenzoic acid oxidation of 5-bromo-2-(methoxymethoxy)benzaldehyde, has been characterised by IR and NMR spectroscopy and X-ray diffraction. The structure features two independent molecules with a π–π stacking interaction between them.

Graphical Abstract

1. Introduction

Ever since salicylaldehyde 1 was first studied in the mid-19th century, it was observed to undergo dehydrative dimerisation, particularly under acidic conditions, to give a compound variously described as “parasalicyl” [1,2] and disalicylaldehyde [3]. There were various suggestions as to its structure and in a definitive paper of 1922 [4] this was finally shown by chemical methods to be the interesting dibenzo-fused trioxabicyclo[3.3.1]nonadiene 2 (Scheme 1). The activity of substituted derivatives of 2 as antimicrobial agents has been reported [5].
In the course of recent synthetic work, we were carrying out a Baeyer–Villiger oxidation of the methoxymethyl-ether-protected 5-bromosalicylaldehyde 3 to give the protected bromocatechol 4 and, in addition to the expected product, obtained a minor by-product in low yield which turned out to be the dibromo derivative of disalicylaldehyde 5 (Scheme 2). This has only been mentioned once before in a 1940 paper where it was obtained by direct bromination of 2 and only a melting point was given [6]. We describe here the full characterisation of this compound including its IR and NMR spectra and X-ray structure determination.

2. Results

The starting compound 3 was prepared according to a literature procedure [7] and subjected to m-chloroperoxybenzoic acid (m-CPBA) oxidation as described in a patent [8]. We faced significant difficulty in separating the desired product 4 from the m-chlorobenzoic acid and even after several washings had to subject the residue to column chromatography. This did give the required product 4 in 75% isolated yield after a further recrystallisation, but a fast-running minor component was also obtained which proved to be the unexpected dibromodisalicylaldehyde 5 (4%). In addition to NMR signals for a 1,2,4-trisubstituted benzene ring (see Supplementary Materials), this had a distinctive singlet at δH 6.28 and δC 89.4 ppm in agreement with expectation for a benzylic ArCH(OR)2 environment. The IR spectrum showed no significant signals above 1650 cm–1 confirming the absence of OH and C=O. The material failed to give any meaningful mass spectrometric data.
Recrystallisation from hexane gave colourless prisms suitable for X-ray diffraction and the resulting structure (Figure 1) shows two independent but closely similar molecules in the unit cell. At 1.888(8)–1.892(8) Å the C–Br distances are rather short compared to the mean value of 1.899 Å for ArC–Br [9]. Two views of the molecule (Figure 2) show that the central trioxabicyclo[3.3.1] ring system is symmetrical and distinctly angular.
As far as we are aware, only six compounds with this core structure have been previously characterised by X-ray diffraction (Figure 3) and the key geometric parameters for these are compared with 5 in Table 1. It can be seen that these form a relatively consistent pattern with the possible exception of the parent compound 2 which has longer bridging C–O bonds, a larger angle at the ring oxygens and a smaller angle between the mean planes. This last parameter is the angle between the planes defined by the five atoms making up each of the three-atom bridges in the bicyclo[3.3.1] system, i.e., CH–O–C=C–CH.
The other main feature of the crystal structure of 5, which is not evident in Figure 1, is the arrangement of adjacent pairs of independent molecules to allow a favourable π–π stacking interaction between them (Figure 4, distance between two mean planes 3.384 Å, centroid···centroid distance 3.602(6) Å). Among the six other structures of Figure 3 this feature only seems to occur for 2 (distance between two mean planes 3.264 Å). We assume that the presence of bulky substituents in the other cases prevents this arrangement.
In summary, the dibromodisalicylaldehyde 5 obtained as a minor by-product has been spectroscopically characterised for the first time and its X-ray crystal structure consist of pairs of independent molecules in a π–π stacking arrangement.

3. Experimental

Melting points were recorded on a Reichert hot-stage microscope (Reichert, Vienna, Austria) and are uncorrected. IR spectra were recorded using the ATR technique on a Shimadzu IRAffinity 1S instrument. NMR spectra were obtained using a Bruker AV300 instrument (Bruker, Billerica, MA, USA). Spectra were run with internal Me4Si as the reference and chemical shifts are reported in ppm to high frequency of the reference.

3.1. Reaction Leading to Formation of 5

A solution of 5-bromo-2-methoxymethoxybenzaldehyde 3 [7] (20.0 g, 81.6 mmol) and m-chloroperoxybenzoic acid (28.8 g, 116.7 mmol) in CH2Cl2 (300 mL) was stirred at RT for 18 h. The mixture was filtered and the filtrate was stirred with 2 M aqueous Na2S2O3 for 2 h. The organic layer was separated, dried and evaporated to give a solid (25.3 g). Column chromatography of this (SiO2, hexane/EtOAc, 4:1) gave, as the first fraction, by-product 5 (0.66 g, 4%) followed by the desired product 4 (14.35 g, 75%) which had data in agreement with the published values [8].
Data for 5: mp 157–159 °C (lit. [6] 168 °C); IR: νmax/cm–1 1607, 1477, 1412, 1265, 1221, 1184, 1132, 957, 881, 858, 814; 1H NMR (300 MHz, CDCl3, 25 °C): δ 6.28 (2H, s, OCHO, H-6,12), 6.79 (2H, d, J 6.6 Hz, H-4,10), 7.36 (2H, dd, J 6.6, 1.8 Hz, H-3,9), 7.42 (2H, d, J 1.8 Hz, H-1,7); 13C NMR (75 MHz, CDCl3, 25 °C): δ 89.4 (2CH, OCHO, C-6,12), 113.9 (2C, C-2,8), 118.6 (2CH, C-4,10), 121.3 (2C, C-6a,12a), 130.1 (2CH, C-1,7), 134.2 (2CH, C-3,9), 149.4 (2C, C-4a,10a). 13C NMR assignments for CH confirmed by HSQC. Recrystallisation of 5 from hexane gave crystals suitable for X-ray diffraction.

3.2. X-ray Structure Determination of 5

X-ray diffraction data for compound 5 was collected at 173 K using a Rigaku FR-X Ultrahigh Brilliance Microfocus RA generator/confocal optics with XtaLAB P200 diffractometer [Mo Kα radiation (λ = 0.71073 Å)]. Data were collected and processed (including correction for Lorentz, polarization and absorption) using CrysAlisPro [15]. Structures were solved by dual-space methods (SHELXT) [16] and refined by full-matrix least-squares against F2 (SHELXL-2019/3) [17]. Non-hydrogen atoms were refined anisotropically, and hydrogen atoms were refined using a riding model. All calculations were performed using the Olex2 [18] interface.
Crystal data for C14H8Br2O3, M = 384.02 g mol–1, colourless prism, crystal dimensions 0.09 × 0.08 × 0.06 mm, triclinic, space group P-1 (No. 2), a = 6.9692(3), b = 9.2930(4), c = 21.4788(10) Å, α = 97.000(4), β = 97.013(4), γ = 110.805(4) °, V = 1270.00(10) Å3, Z = 4, Dcalc = 2.008 g cm–3, T = 173 K, R1 = 0.0798, wR2 = 0.1442 for 4246 reflections with I > 2σ(I), and 343 variables, Rint 0.0422, Goodness of fit on F2 1.323. Data have been deposited at the Cambridge Crystallographic Data Centre as CCDC 2290326. The data can be obtained free of charge from the Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/getstructures.

Supplementary Materials

The following supporting information can be downloaded at: 1H and 13C and HSQC NMR and IR data as well as cif and check-cif files for 5.

Author Contributions

A.J.L. prepared the compound, D.B.C. and A.P.M. collected the X-ray data and solved the structure; R.A.A. designed the study, analysed the data, and wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

The X-ray data are at CCDC as stated in the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ettling. Ueber die Distillationsproducte des salicyligsauren und benzoësauren Kupferoxyds. Liebigs Ann. Chem. 1845, 53, 77–90. [Google Scholar] [CrossRef]
  2. Cahours, A. Untersuchungen über das Phenol (Phenylhydrat). Liebigs Ann. Chem. 1851, 78, 225–228. [Google Scholar] [CrossRef]
  3. Perkin, W.H. Ueber Benzosalicyl- und Disalicylwasserstoff. Liebigs Ann. Chem. 1868, 145, 295–301. [Google Scholar] [CrossRef]
  4. Adams, R.; Fogler, M.F.; Kreger, C.W. The structure of disalicyl aldehyde. J. Am. Chem. Soc. 1922, 44, 1126–1133. [Google Scholar] [CrossRef]
  5. Fiedler, H. Derivate des 2-Hydroxy-3-methoxy-benzaldehyds. Arch. Pharm. 1964, 297, 226–235. [Google Scholar] [CrossRef] [PubMed]
  6. Tamaki, T.; Endo, Z. Action of phosphorus pentoxide on organic compounds I. Reaction between salicylaldehyde and phosphorus pentoxide. Nippon Kagaku Kaishi 1940, 61, 231–233. [Google Scholar]
  7. Nevesely, T.; Daniliuc, C.G.; Gilmour, R. Sequential energy transfer catalysis: A cascade synthesis of angularly-fused dihydrocoumarins. Org. Lett. 2019, 21, 9724–9728. [Google Scholar] [CrossRef] [PubMed]
  8. Hagihara, M.; Tanaka, M.; Katsube, T.; Okudo, M.; Iwase, N.; Shigetomi, M.; Kanda, T.; Nakanishi, T. Pyrrolopyridazinone Compound. European Patent 1982986 A1, 22 October 2008. [Google Scholar]
  9. Allen, F.H.; Kennard, O.; Watson, D.G.; Brammer, L.; Orpen, A.G.; Taylor, R. Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds. J. Chem. Soc. Perkin Trans. 2 1987, S1–S19. [Google Scholar] [CrossRef]
  10. Bachet, B.; Brassy, C.; Guidi-Morosini, C. Epoxy-8,16 Dihydro-8,16 Dinaphto[2,1-b:2′,1′-f][dioxocinne-1,5]. Acta Crystallogr. Sect. C 1986, 42, 1630–1632. [Google Scholar] [CrossRef]
  11. Vol’eva, V.B.; Belostotskaya, I.S.; Shishkin, O.V.; Struchkov, Y.T.; Ershov, V.V. Synthesis and structures of anhydrodimers of salicylaldehydes. Russ. Chem. Bull. 1995, 44, 1489–1491. [Google Scholar] [CrossRef]
  12. Wang, L.-H.; Lin, D.-D. The crystal structure of 4,10-ethoxy-6H,12H-6,12-epoxydibenzo[b,f][1,5]dioxocine, C18H18O5. Z. Kristallogr. New Cryst. Struct. 2019, 234, 673–674. [Google Scholar] [CrossRef]
  13. Stomberg, R.; Li, S.; Lindquist, K. Crystal structure of 4,10-dimethoxy-6,12-epoxy-6H,12H-dibenzo[b,f][1,5]dioxocin, C16H14O5. Z. Kristallogr. Cryst. Mater. 1995, 210, 967–968. [Google Scholar] [CrossRef]
  14. Ragot, J.P.; Prime, M.E.; Archibald, S.J.; Taylor, R.J.K. A novel route to preussomerins via 2-arylacetal anions. Org. Lett. 2000, 2, 1613–1616. [Google Scholar] [CrossRef] [PubMed]
  15. CrysAlisPro, v1.171.42.94a; Rigaku Oxford Diffraction, Rigaku Corporation: Tokyo, Japan, 2023.
  16. Sheldrick, G.M. SHELXT—Integrated space-group and crystal structure determination. Acta Crystallogr. Sect. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  17. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. Sect. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  18. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
Scheme 1. Formation and structure of “disalicylaldehyde” 2.
Scheme 1. Formation and structure of “disalicylaldehyde” 2.
Molbank 2023 m1729 sch001
Scheme 2. Formation of compound 5.
Scheme 2. Formation of compound 5.
Molbank 2023 m1729 sch002
Figure 1. Molecular structure of 5 showing the two independent molecules with anisotropic displacement ellipsoids drawn at 50% probability level (hydrogen atoms are shown as grey spheres of arbitrary size) and the numbering system used.
Figure 1. Molecular structure of 5 showing the two independent molecules with anisotropic displacement ellipsoids drawn at 50% probability level (hydrogen atoms are shown as grey spheres of arbitrary size) and the numbering system used.
Molbank 2023 m1729 g001
Figure 2. Two alternative views of 5 showing the symmetrical and distinctly angular shape of the molecule (carbon atoms—dark grey, hydrogen atoms—light grey, oxygen atoms—red, bromine atoms—brown).
Figure 2. Two alternative views of 5 showing the symmetrical and distinctly angular shape of the molecule (carbon atoms—dark grey, hydrogen atoms—light grey, oxygen atoms—red, bromine atoms—brown).
Molbank 2023 m1729 g002
Figure 3. Crystallographically characterised disalicylaldehyde derivatives with CSD Ref Codes.
Figure 3. Crystallographically characterised disalicylaldehyde derivatives with CSD Ref Codes.
Molbank 2023 m1729 g003
Figure 4. Crystal structure of 5 viewed along the crystallographic a axis showing π–π stacking interactions (arrows) between pairs of independent molecules.
Figure 4. Crystal structure of 5 viewed along the crystallographic a axis showing π–π stacking interactions (arrows) between pairs of independent molecules.
Molbank 2023 m1729 g004
Table 1. Comparison of selected geometric parameters for 5 and related compounds (Å, °).
Table 1. Comparison of selected geometric parameters for 5 and related compounds (Å, °).
CompdBridging
C–O Length (s)
Angle at
Bridging O
Angle(s) at
Ring Os
Angle between
Mean Planes
Ref
51.404 (10), 1.410 (11)109.6 (6)111.6 (6), 112.4 (7)72.9This work
51.403 (11), 1.407 (11)109.9 (6)112.5 (6), 112.7 (6)73.5This work
6 FADVOV1.418108.6112.3 (2)71.7[10]
2 ZIZSAC1.549106.5117.9 (9)65.9[11]
7 TOLDAC1.415(2), 1.417(2)108.0(1)111.4(1), 111.9(1)73.5[12]
8 ZOLBOR1.411(3), 1.416(3)107.8(2)111.5(2), 111.7(2)72.75[13]
9 UGIPIJ1.408(5), 1.414(5)109.3(3)112.2(2), 112.3(3)72.75[14]
10 UGIPEF1.413(2), 1.417(2)111.0(1)112.6(1), 113.1(1)73.6[14]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Aitken, R.A.; Cordes, D.B.; Ler, A.J.; McKay, A.P. 2,8-Dibromo-6H,12H-6,12-epoxydibenzo[b,f][1,5]dioxocine. Molbank 2023, 2023, M1729. https://doi.org/10.3390/M1729

AMA Style

Aitken RA, Cordes DB, Ler AJ, McKay AP. 2,8-Dibromo-6H,12H-6,12-epoxydibenzo[b,f][1,5]dioxocine. Molbank. 2023; 2023(3):M1729. https://doi.org/10.3390/M1729

Chicago/Turabian Style

Aitken, R. Alan, David B. Cordes, An Jie Ler, and Aidan P. McKay. 2023. "2,8-Dibromo-6H,12H-6,12-epoxydibenzo[b,f][1,5]dioxocine" Molbank 2023, no. 3: M1729. https://doi.org/10.3390/M1729

APA Style

Aitken, R. A., Cordes, D. B., Ler, A. J., & McKay, A. P. (2023). 2,8-Dibromo-6H,12H-6,12-epoxydibenzo[b,f][1,5]dioxocine. Molbank, 2023(3), M1729. https://doi.org/10.3390/M1729

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop